VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Firesorb Bioresorbable Scaffold Shows 94.8% Freedom from TLF at 5-Year Follow-Up in FUTURE-II Trial, Presented at EuroPCR 2026
Firesorb Bioresorbable Scaffold Shows 94.8% Freedom from TLF at 5-Year Follow-Up in FUTURE-II Trial, Presented at EuroPCR 2026
May 21, 2026 19:30 CST Updated May 22, 02:29
Share:
